baber/WOPTO huggingface dataset:
Patent NZ-534513-A (NZ)
Title: Pharmaceutical formulation of iressa comprising a water-soluble cellulose derivative
Inventor: GELLERT PAUL RICHARD
IPC: A61K/
Filed: 2003-02-24
Abstract: Disclosed is a pharmaceutical composition comprising 4-(3'-chloro-4'-fluoroanilino)-7-methoxy-6-(3-morpholinopropoxy)quinazoline or a pharmaceutically acceptable salt thereof (the Agent) and a water-soluble cellulose ether or an ester of a water-soluble cellulose ether; and a use of this composition in the manufacture of a medicament for inhibiting the rate of precipitation of 4-(3'-chloro-4'-fluoroanilino)-7-methoxy-6-(3-morpholinopropoxy)quinazoline or a pharmaceutically-acceptable salt thereof from solution in the gastro intestinal (GI) tract of a warm-blooded mammal.
Patent NZ-534633-A (NZ)
Title: System for permission-based communication and exchange of information for market research purposes
Inventor: CHAN PAUL AUGUSTINE
IPC: G06Q30/02
Filed: 2003-02-19
Abstract: A method and system for permission-based information exchange is disclosed. The method includes the steps of: (a) receiving consumer information corresponding to a plurality of individual consumers via a consumer information receiver, where the consumer information includes both consumer-identifying information and consumer profile information for each consumer, (b) storing the consumer-identifying information in consumer-identifying records in a consumer database, (c) storing the consumer profile information in consumer profile records in the consumer database, (d) receiving a profile information search request from a requestor via a search request receiver, wherein the search request specifies at least one consumer profile criterion, (e) searching the consumer database to identify selected consumer profile records containing consumer profile information which match the consumer profile criterion in order to obtain a search result, and (f) providing the search result to the requestor via a search result provider, wherein the search result does not include any consumer-identifying information.
Patent NZ-535366-A (NZ)
Title: Substituted tetrahydroisoquinoline compounds, methods of making, and their use
Inventor: MILLER DUANE D
IPC: C07C211/27
Filed: 2003-03-13
Abstract: Disclosed is a compound according to formula (I) wherein: R1, R2, R3 and R4 are independently H or OH; R5, R6 and R7 are independently H or alkyl; R8 is H, alkyl, aryl or arylalkyl; R9 is of formula (II); R10 is H; and R11, R12 and R13 are independently selected from the group consisting of H, OH, halide, alkyl, arylalkyl, alkenyl, arylalkenyl, alkoxy, aryloxy, amino, alkylamino, dialkylamino, arylamino, aryl and cyclohexyl.
Patent NZ-537765-A (NZ)
Title: Panel/gate interconnection means for a collapsible materials handling container
Inventor: WINN ARTHUR RAYMOND
IPC: B65D6/16
Filed: 2002-08-08
Abstract: Disclosed is a collapsible storage container (Figure 1) which has a first pair of folding side gates (11) and a second pair of folding end gates (12), with each gate (11,12) being pivotally mounted with respect to a pallet base. Each gate (11) has detachably mounted along opposite vertical margins thereof approximately c-shaped posts (22) each of which has a locking flange (23). Each gate (12) has angle members (35) attached to and extending along opposite vertical frame members (30, 31) and forming therewith a flange receiving slot (40) for slidably locating a respective locking flange (23). The gates (11,12) when in their erect positions interlock with one another along their adjacent vertical margins which enhances the stiffness and rigidity of the container (10).
Patent NZ-542214-A (NZ)
Title: Unitized thermoplastic foam mattress
Inventor: BARMAN BRUCE G
IPC: A47C27/14
Filed: 2004-02-19
Abstract: A unitised thermoplastic foam structure mattress including an innerspring having a plurality of spring elements 120 arranged in an array and defining a first support side, a second support side parallel to the first support side, and a perimeter about the first and second support sides, a foam deck 22 adjacent one of the support sides of the innerspring, the foam deck 200 having a plurality of box beam segments 202 with first and second panels and at least one web between the first and second panels, and at least one additional foam component welded to the foam deck.
Patent NZ-543154-A (NZ)
Title: Pyrroloimidazole derivatives, their preparation, pharmaceutical composition containing them, and their use as nootropic agents
Inventor: FARINA CARLO
IPC: C07D487/04
Filed: 2004-03-22
Abstract: Disclosed herein are new bicyclic arylimidazolones having nootropic action (i.e., protecting and stimulating cerebral functions), analgesic action and anti hyperalgesic action; also disclosed is the process for their preparation and pharmaceutical compositions comprising them, useful for the treatment of cognitive deficits, and of various types of pain.
Patent NZ-546605-A (NZ)
Title: Sandwich press and grill
Inventor: SERRA DANIEL
IPC: E05D11/10
Filed: 2004-10-13
Abstract: There is provided a toaster grill (100) having a lower housing (102) that supports a lower cooking surface (104) and an upper housing (109) that supports an upper cooking surface (110). The upper housing pivots with respect to a "U" shaped frame (204) that is hinged with respect to the lower cooking surface. A locking hinge (108) allows the pivoting motion of the frame to be automatically arrested in an intermediate orientation between the fully closed and fully open grill orientations. The upper cooking surface has ribs (4910). The lower cooking surface is tilt adjustable. A drip tray (106) is carried by the lower housing.
Patent NZ-550825-A (NZ)
Title: Method and apparatus for implementing threshold based correction functions for biosensors
Inventor: MECKLENBURG GEORGE A
IPC: C12Q1/00
Filed: 2005-03-31
Abstract: A method for implementing threshold based correction functions for a biosensor is provided. The method includes the steps of: applying a sample to the biosensor and obtaining a primary measurement of an analyte value; obtaining a secondary measurement of a secondary effect; comparing the secondary measurement of the secondary effect with a threshold value; responsive to said compared values, identifying a correction function using at a coefficient value, the coefficient value being dependent upon the primary measurement of said analyte value; and applying the identified correction function to the primary measurement to provide a corrected analyte value. An apparatus including a biosensor and a processor to run the method is also disclosed.
Patent NZ-553275-A (NZ)
Title: Hard material bit
Inventor: HEEMANN KAY
Filed: 2007-02-19
Abstract: A hard material bit for a drilling head (2) includes at least two cutting edges (4a, 4b) over a bit length (L) in a direction transverse to a bit drilling axis (A), with one of the at least two cutting edges (4a) being located adjacent to a first side surface (5a) of the bit and another of the at least two cutting edges being located adjacent to the second side surface (5b) of the bit spaced form the first side surface by a thickness (D), the bit further including a base surface (6) located opposite the cutting edges at a height (H) along the drilling axis (A), and two recesses (7a, 7b) formed in respective longitudinal portions of the base surface located opposite the one and the another of the at least two cutting edges, respectively, and extending up to the first and second side surfaces, respectively.
Patent NZ-553414-A (NZ)
Title: Barb configurations for barbed sutures
Inventor: LEUNG JEFFERY C
IPC: A61B17/04
Filed: 2003-09-29
Abstract: A barbed suture for connecting human or animal tissue, the suture comprising (a) an elongated body having a first end and a second end and a diameter and (b) a plurality of barbs projecting from the body, each barb facing in a direction and being adapted for resisting movement of the suture, when in tissue, in an opposite direction from the direction in which the barb faces, wherein the barbs have a configuration comprising a corrugated barb underside.
Patent NZ-560966-A (NZ)
Title: Nucleic acids and proteins from streptococcus groups A & B
Inventor: TELFORD JOHN
IPC: C07K14/315
Filed: 2001-10-29
Abstract: Disclosed is a vaccine composition comprising; an isolated protein comprising a specific amino acid sequence; and alum. Further disclosed is the use of an isolated protein comprising a specific amino acid sequence; and alum in the manufacture of a medicament for the treatment or prevention of infection or disease caused by Streptococcus bacterium.
Patent NZ-562967-A (NZ)
Title: Breath actuated drug delivery system with nasal delivery
Inventor: WILLIAMS ROBERT
IPC: A61M15/00
Filed: 2006-05-09
Abstract: A nasal drug delivery system comprises a container 110 containing a substance to be delivered into the nasal passages of a user, a nasal shaft 108 extending from the drug delivery system for placement in or around the nose of user and in fluid communication with a valve of the container, the valve comprising a vertical lumen 132 and an angled lumen 134, an oral shaft 106 extending from the drug delivery system for placement in the mouth of a user, and a pressure activated diaphragm 120 trigger means. Upon application of pressure to the oral shaft the diaphragm trigger means releases a predetermined amount of the substance from the container 110 to the nasal shaft 108. The pressure activated diaphragm trigger means comprises a follower assembly 114, a follower 116, and a cam 118.
Patent NZ-565287-A (NZ)
Title: Novel milk protein fractions and use thereof for preventing or treating chronic inflammatory diseases
Inventor: MIKOGAMI TAKASHI
IPC: A23L33/00
Filed: 2006-07-25
Abstract: Disclosed is a process for preparing a milk protein fraction wherein it comprises the following steps: milk or whey are used as starting material; (a) the milk or whey is optionally subjected to a microfiltration or to a heat treatment; (b) the milk or whey or the product derived from step (a) is deposited on a cation-exchange resin; (c) the cation-exchange resin is washed with demineralized water; (d) the resin is eluted with brine solutions of increasing concentration; (e) an eluate corresponding to a brine solution with a conductivity of between 21.0 and 22.0 mS/cm is recovered. Also disclosed is the milk protein fraction obtained by the process, the use of said protein in the preparation of a medicament for the prevention or treatment of chronic inflammatory pathological conditions for example, psoriasis and a composition comprising said protein.
Patent NZ-570681-A (NZ)
Title: Ultraviolet lamp for use in water purifiers
Inventor: ZAYAS BETTY JEAN
IPC: H01R13/73
Filed: 2007-02-15
Abstract: A lamp is provided with terminal pins 48, 50, 52, 54 mounted on and extending outwardly along a longitudinal axis of an end cap 44 of the lamp. The pins are offset relative to one another along the longitudinal axis. The end cap 44 has semi-circular, parallel surfaces 72, 74 at one end, and the pins extend outwardly from the respective semi-circular, parallel surfaces. A barrier wall 70a, 70b extends substantially perpendicularly between the semi-circular surfaces. In a first embodiment, a male extension member 75 extends outwardly from the barrier wall along at least a portion of the lower semi-circular surface. This male extension is coextensive with the upper semi-circular surface. Alternatively, in a second embodiment, a female recess is provided through the boundary wall. This recess again extends between the upper and lower semi-circular surfaces.
Patent NZ-571743-A (NZ)
Title: Compositions and methods for surface modification of root vegetable products
Inventor: SAHAGIAN MICHAEL
IPC: A23L19/12
Filed: 2007-03-21
Abstract: Disclosed is a method of modifying a root vegetable product comprising contacting the surface of the root vegetable product with an effective amount of enzyme in order to modify the surface of the root vegetable; drying the root vegetable product while contacting the surface with the enzyme, by air drying in a dryer, wherein the contacting step and the drying step are partially concurrent or fully concurrent.
Patent NZ-571941-A (NZ)
Title: Method for extracting components from a yeast cell culture
Inventor: KALUM LISBETH
IPC: C12N1/06
Filed: 2007-05-03
Abstract: Disclosed is a method for producing a yeast extract, the method comprising: i) treating yeast cells with a purified phospholipase; and ii) separating the yeast extract from the treated yeast cells, wherein the yeast cells are subjected to protein hydrolysis before, after, or during step i). Also disclosed is the use of a purified phospholipase on yeast cells to produce a yeast extract.
Patent NZ-574216-A (NZ)
Title: Treatment of cartilage disorders with fgf-18
Inventor: GIMONA ALBERTO
IPC: A61K31/18
Filed: 2007-08-24
Abstract: Disclosed is the use of an FGF-18 compound in the manufacture of a medicament for the treatment of a cartilage disorder wherein the medicament is formulated for administration for at least 3 consecutive weeks per treatment cycle, said administrations being separated by about 6, 7 or 8 days.
Patent NZ-577345-A (NZ)
Title: A set of floor panels with a locking system having a sideways displaceable tongue at an edge of a panel
Inventor: BERGELIN MARCUS
IPC: E04F15/04
Filed: 2007-09-24
Abstract: A set of floor panels is disclosed. The set of floor panels is provided with a locking system comprising a displaceable tongue provided at an edge of a floor panel for locking the edge vertically to an adjacent edge of a similar adjacent floor panel. At least a part of the displaceable tongue is displaced into a tongue groove at the adjacent edge of the adjacent floor panel and the locking is accomplished by a sideway pressure applied at an edge section of the displaceable tongue and essentially along the edge.
Patent NZ-578097-A (NZ)
Title: Wrench with socket, handle and retainer
Inventor: NASH DEREK J
IPC: B23G1/46
Filed: 2008-03-13
Abstract: A wrench is disclosed and includes: a handle connected to a housing; a socket for receiving a device, the socket supported in the housing and defined by a plurality of first faces; a retainer, defining an opening, the opening has a plurality of second faces. The retainer is supported on the housing and can move between a first position and a second position. When in the first position, the retainer at least partially overlies the socket.
Patent NZ-585757-A (NZ)
Title: Agricultural or horticultural spraying apparatus with partial recirculation of pumped fluid to back to tank
Inventor: EASTON CAMPBELL BRYCE
IPC: A01M7/00
Filed: 2011-05-24
Abstract: A spraying apparatus is disclosed that is stated to be particularly suited to spraying of suspensions, for example liquid suspended fertilizers. Spray outlets are arranged in a flow loop arid only a proportion of fluid passing through the flow loop is sprayed with the remaining fluid returning to the tank for recirculation. Pressure-actuated closures may be used to prevent spraying until pressure has built up sufficiently. The apparatus may include a tank with an inlet configured to create fluid circulation within the tank?thereby reducing settling of solids out of suspension. A mixing unit improves the mixing of particulates with fluids as they are added to the tank.
Patent NZ-586465-A (NZ)
Title: Method of inhibiting hepatocyte transport protein OATP1B1 expression in a hepatocyte
Inventor: BROUWER KIM L R
IPC: C12N5/071
Filed: 2005-05-10
Abstract: A method of inhibiting expression of a protein in a hepatocyte by providing a hepatocyte expressing the OATP1B1 transport protein and introducing an oligonucleotide that has a nucleotide sequence corresponding to a coding strand of a gene encoding the OATP1B1 transport protein in an amount sufficient to inhibit expression of the protein.
Patent NZ-587561-A (NZ)
Title: Method and system for the treatment of chronic obstructive pulmonary disease with nebulized anticholinergic administrations (an muscarinic antagnoist)
Inventor: GERHART WILLIAM
IPC: A01N45/00
Filed: 2009-02-26
Abstract: Disclosed is the use of a unit dose of glycopyrrolate for the manufacture of a medicament for the treatment of chronic obstructive pulmonary disease (COPD), wherein the unit dose comprises a therapeutically effective amount of up to 250µg of glycopyrrolate as the sole therapeutic agent and wherein the medicament is adapted for administration by a nebulizer. Further disclosed is the use of a unit dose of glycopyrrolate for the manufacture of a medicament for the relief of one or more symptoms of chronic obstructive pulmonary disease (COPD) for at least 24 hours, wherein the unit dose comprises a therapeutically effective amount of up to 250µg of glycopyrrolate as the sole therapeutic agent, and wherein the medicament is an aqueous inhalation solution adapted for administration by a high efficiency nebulizer.
Patent NZ-588102-A (NZ)
Title: Liner for repairing a lateral connection of a pipeline with integral transition region between main lining part and lateral lining part.
Inventor: BATEMAN IAN
IPC: F16L55/165
Filed: 2009-02-27
Abstract: A liner (5) is disclosed for repairing a connection between a main pipeline and a lateral pipe. The liner includes a main pipeline lining part (12) that in use forms a tubular portion for lining an inner circumferential portion of the main pipeline and a lateral pipe lining part (14) that in use forms a tubular portion for lining an inner circumferential portion of the lateral pipe. Between the lateral pipe lining part (14) and the main pipe lining part (12) there is a transition zone (16) that in use is arranged to line a junction zone between the main pipeline and the lateral pipe. The transition zone (16) is formed integrally with both the main pipeline lining part (12) and the lateral pipe lining part (14).
Patent NZ-588306-A (NZ)
Title: Use of galactooligosaccharides and the polyfructose inulin for the treatment of diseases of the bowel
Inventor: SPEELMANS GELSKE
IPC: A23L33/00
Filed: 2005-05-17
Abstract: The use of galacto-oligosaccharides and polyfructose for the treatment or prevention of abdominal bloating, gas formation, abdominal pain and/or flatulence. The polyfructose is inulin with an average degree of polymerisation above 20. The composition can promote the production of short chain fatty acids in the colon and is suitable for infant nutrition.
Patent NZ-591758-A (NZ)
Title: Reflective Ground Cover material
Inventor: TOYE JONATHAN DALLAS
IPC: A01G13/00
Filed: 2011-03-16
Abstract: 591758 A reflective ground cover sheet material woven from warp and weft tapes of a plastics material wherein the average gap (g) between edges of adjacent tapes in both the warp and the weft direction is in the range about 0.l mm to about 1.2 mm and wherein the material is reflective of at least 50% of visible light (wavelength about 400-700nm) on at least one side of the material.
Patent NZ-592367-A (NZ)
Title: Amidoacetonitrile compounds and pesticidal composition thereof
Inventor: GAUVRY NOELLE
IPC: A01N39/00
Filed: 2009-12-02
Abstract: 592367 Disclosed are compounds of the general formula (I) wherein the variable have the meanings as specified, and optionally the enantiomers thereof. The active ingredients have advantageous pesticidal properties. They are especially suitable for controlling endoparasites on warm-blooded animals. An example of a compound of formula (I) is N-[1-cyano-1-methyl-2-(5-cyano-2-{ 2-chloro-4-trifluoromethoxy-phenoxy} -phenoxy)-ethyl]-4-pentafluorothio-benzamide.
Patent NZ-597742-A (NZ)
Title: Method of producing a polypeptide or virus of interest in a continuous cell culture
Inventor: GRILLBERGER LEOPOLD
IPC: C12N5/00
Filed: 2010-08-02
Abstract: 597742 Disclosed is a method for producing a polypeptide and/or virus of interest in a serum-free continuous cell culture, said method comprising: (a) culturing mammalian cells expressing the polypeptide and/or virus of interest in a continuous cell culture system, wherein said cells are cultured in a serum-free medium and wherein said cell culture system comprises a cell retention device that produces a cell retention rate of less than 90%; has a dilution rate (D) of less than 0.6 d-1; and a specific growth rate of between 0.15 d-1 to 0.25 d-1; and (b) recovering said polypeptide and/or virus of interest from medium removed from said cell culture system.
Patent NZ-600097-A (NZ)
Title: Rotary device and rotary drive
Inventor: HUNTER IAN W
IPC: B60G17/015
Filed: 2010-11-05
Abstract: Disclosed is a rotary device with a linear-to-rotary converter (105) with a rotational axis and a magnetic stator assembly (120) including a core having one or more magnets (445a, 445b) producing magnetic fields. Also included are two electromagnetic actuators (115a, 115b) each including a reciprocating coil circumscribing the core and at least some of the one or more magnets (445a, 445b) of the core and are arranged to reciprocate relative to the magnetic stator assembly (120). The reciprocating coils are located opposite each other relative to the rotational axis and each reciprocating coil is coupled to the linear-to-rotary converter (105) to drive the linear-to-rotary converter (105).
Patent NZ-606834-A (NZ)
Title: Mobility aid
Inventor: LITTLE RICHARD
IPC: A61F5/00
Filed: 2008-12-24
Abstract: 606834 According to a first aspect there is provided a walking aid (WA) (100) usable as a medical device, suitable for supporting a mobility impaired disabled user while moving through a set of movements correlating to a walking motion. The WA (100) comprises an exoskeleton (500), a power source in the form of a battery pack or other similar onboard power pack (not shown) together with its associated power supply cables (not shown), and a control system (not shown). an The exoskeleton (500) comprises a rigid pelvic support member or hip frame (15) including a pelvic harness, and a pair of leg structures (a first leg structure and second leg structure). Each of the leg structures comprise an upper leg structural member (10), a lower leg structural member (11), a foot member (18), a main hip actuator, a knee actuator (13) and a main foot actuator (19). The upper leg structural member (10) is for securing with an upper leg of a user, the upper leg structural member (10) being pivotally engaged at a first end thereof to the hip frame (15) by the hip joint. The lower leg structural member (11) is for securing with the lower leg of the user, the lower leg structural member (11) being pivotally engaged at a first end thereof to a second end of the upper leg structural member (10) by a knee joint (12). At a first end (10) of the upper leg member (10) is a hip joint that pivotally engages the upper leg member (10) with the hip frame (15). The hip joint defines a hip axis that in use is located relative to the user at or approximate to the natural axis of hip rotation in an anterior/posterior direction of movement. In a preferred embodiment, each hip joint is configured relative to the hip frame (15) with its axis of rotation extending downwardly in a lateral direction at an angle of between zero and ten degrees, and more preferably of about four degrees. This inclination of the axis of rotation mimics a human beings upper leg alignment. The inclination allows for more natural transfer of the centre of mass (generally located about the middle of the pelvis) to a point within the support area provided by the foot member (18) during when the WA (100) is controlled in a natural walking movement.